Although an effective and critical therapeu-
Beijing Tiantan Hospital, Capital Medical Univeirsity, China Background and Aims: Although an effective and critical therapeutic modality for scarring airway stenosis, the efficacy of interventional bronchoscopy differs among different studies. Thus, factors associated with the efficacy of interventional bronchoscopy and restenosis are not clearly understood. In this study, the clinical factors associated with the achievement of clinical success were specifically evaluated, and the variables associated with airway restenosis addressed.
Methods: Between January 2013 to December 2016, 301 patients with scarring airway stenosis from 18 tertiary hospitals, who were treated by interventional bronchoscopy were reviewed retrospectively. Airway stenosis characteristics and patients' performance status at baseline and after interventional bronchoscopy were recorded. The methods of interventional bronchoscopy included electric knife cutting, laser cauterization, balloon dilation, cryotherapy, and/or stenting. The interval days between the first two interventional bronchoscopy treatment (maintained patency time) were recorded.
Results:
The final clinically stability rate of interventional bronchoscopy for the treatment of scarring tracheal stenosis was 67.8% (204/301). Stenosis sites (P = 0.032), dyspnea index (P < 0.001), and interventional method (P = 0.005) were independent predictors associated with the efficacy of interventional bronchoscopy treatment. The mean maintain patency time after the first interventional bronchoscopy treatment was 26.9 AE 30.9 days. Stenosis sites (P < 0.001), stenosis grade (P = 0.001), anaesthesia method (P < 0.001), and local drug usage (P < 0.001) were independent predictors associated with the maintained patency time after first interventional bronchoscopy treatment.
Conclusion:
Interventional bronchoscopy is a useful treatment method for scarring airway stenosis. Enough attention should be paid to influence factors to improve treatment efficacy during the treatment process. Background and Aims: Re-biopsy diagnosis is paramount in lung cancer patients with progressive disease after treatment. The endobronchial ultrasound-guided needle aspiration (EBUS-TBNA) was an important method for tissue acquisition. However, the role of EBUS-TBNA for re-biopsy in lung cancer was not clear. In this study, we investigated the feasibility of re-biopsy by EBUS-TBNA in lung cancer with suspected progression or recurrence after treatment.
Methods: Between November 2015 and October 2017, consecutive patients with suspected lung cancer progression or recurrence after treatment who underwent EBUS-TBNA were enrolled in National Taiwan University Hsin-chu Branch. The diagnoses were verified either by surgery or clinical follow-up.
Results: A total of 50 lymph nodes were sampled from 28 patients for suspected lung cancer recurrence (n = 6) or progression (n = 22) by EBUS-TBNA. The accuracy of EBUS-TBNA for the diagnosis of lung cancer progression or progression was 85.7% (24/28). The sensitivity, specificity, positive predictive value, and negative predictive value rate was 84.0%, 100%, 100%, and 42.9%, respectively. Logistic regression analysis revealed that lymph node size significantly influenced the diagnostic yield of EBUS-TBNA. The T790M mutation was identified in 5 (62.5%) of 8 patients with EGFR-mutant lung adenocarcinoma. There was no major complication noted in these patients.
Conclusion: EBUS-TBNA is a suitable re-biopsy method for patients with suspected lung cancer progression or recurrence. Methods: A 28-year-old lady presented to us with the complaints of persistent dry cough and breathlessness for 6 months. She was seen by different physicians several times and was diagnosed as asthma. Despite getting optimum medications for asthma, her condition was deteriorating. On examination, she was anxious and dyspnoeic. Chest auscultation revealed breath sound vesicular with prolonged expiration and bilateral wheezes. SpO 2 94% at room air, chest X-ray revealed normal findings.
Rescue corticosteroid was started along with ongoing medications. Three days later, she presented with worsening dyspnoea. There was inspiratory stridor. Spirometry was consistent with fixed airway obstruction. On query, her husband told that she got admitted to ICU 2 months before the first appearance of present symptoms after suicidal ingestion of benzodiazepine tablet and was on invasive mechanical ventilation for 2 days. Fiberoptic bronchoscopy (FOB) revealed a smooth fibrous narrowing of
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